Company / Working Capital
Enovis Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$608.6M
FY2025
5-year range
$229.8M / $1.3B
FY2021-FY2025
Trend
-1.4%
vs FY2024
Sector context
#53 of 160
Health Care
What the data says
At $609M, Enovis's working capital ranks #53 of 160 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $230M in FY2022 to $1.3B in FY2021.
Based on SEC 10-K filings.
$609M in FY2025 with a 5-year CAGR of +2.0%.
Improved from $527M to $609M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +38.3%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
#53 of 160 in Health CareTop 33% of 160This company $608.6M Sector average $757.1M
▼
-19.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.0%, indicating consistent growth.
- In FY2025, working capital decreased 1.4% year-over-year.
- Ranks #53 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $608.6M | -1.4% |
| FY2024 | $617.4M | +17.2% |
| FY2023 | $526.9M | +129.3% |
| FY2022 | $229.8M | -82.0% |
| FY2021 | $1.3B | +132.6% |
| FY2020 | $550.2M | +0.6% |
| FY2019 | $546.9M | -27.9% |
| FY2018 | $759.1M | -21.9% |
| FY2017 | $972.5M | +43.2% |
| FY2016 | $678.9M | +5.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026